Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Twist Bioscience Corp (TWST)

Twist Bioscience Corp (TWST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,511,288
  • Shares Outstanding, K 58,226
  • Annual Sales, $ 245,110 K
  • Annual Income, $ -204,620 K
  • 60-Month Beta 1.64
  • Price/Sales 10.61
  • Price/Cash Flow N/A
  • Price/Book 4.28
Trade TWST with:

Options Overview Details

View History
  • Implied Volatility 63.65% ( -7.95%)
  • Historical Volatility 90.11%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 103.99% on 11/13/23
  • IV Low 63.65% on 05/08/24
  • Put/Call Vol Ratio 1.15
  • Today's Volume 73
  • Volume Avg (30-Day) 699
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 15,362
  • Open Int (30-Day) 11,642

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.80
  • Number of Estimates 3
  • High Estimate -0.77
  • Low Estimate -0.82
  • Prior Year -1.01
  • Growth Rate Est. (year over year) +20.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.41 +52.75%
on 04/19/24
44.92 -6.79%
on 05/07/24
+8.90 (+26.99%)
since 04/08/24
3-Month
27.41 +52.75%
on 04/19/24
44.92 -6.79%
on 05/07/24
+5.36 (+14.68%)
since 02/08/24
52-Week
11.81 +254.53%
on 05/12/23
44.92 -6.79%
on 05/07/24
+28.47 (+212.46%)
since 05/08/23

Most Recent Stories

More News
Twist Bioscience: Fiscal Q2 Earnings Snapshot

Twist Bioscience: Fiscal Q2 Earnings Snapshot

TWST : 41.89 (-2.88%)
Twist Bioscience: Fiscal Q1 Earnings Snapshot

Twist Bioscience: Fiscal Q1 Earnings Snapshot

TWST : 41.89 (-2.88%)
Twist Bioscience: Fiscal Q4 Earnings Snapshot

Twist Bioscience: Fiscal Q4 Earnings Snapshot

TWST : 41.89 (-2.88%)
Why Shares of Twist Bioscience Are Up Friday

The company reported improved financials in the third quarter.

TWST : 41.89 (-2.88%)
Twist Bioscience: Fiscal Q3 Earnings Snapshot

Twist Bioscience: Fiscal Q3 Earnings Snapshot

TWST : 41.89 (-2.88%)
2 Cathie Wood Growth Stocks That Could Make You Richer

These two biotechs could be winning plays for aggressive investors.

ARKK : 44.46 (-2.39%)
TWST : 41.89 (-2.88%)
EXAS : 59.49 (-3.13%)
Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates

Twist Bioscience (TWST) delivered earnings and revenue surprises of 2.75% and 6.31%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

TWST : 41.89 (-2.88%)
VCEL : 46.86 (-5.37%)
Twist Bioscience: Fiscal Q2 Earnings Snapshot

Twist Bioscience: Fiscal Q2 Earnings Snapshot

TWST : 41.89 (-2.88%)
Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and...

TWST : 41.89 (-2.88%)
Horizon Therapeutics (HZNP) Q1 Earnings and Revenues Lag Estimates

Horizon Therapeutics (HZNP) delivered earnings and revenue surprises of -29.06% and 7.16%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

HZNP : 116.30 (+0.04%)
TWST : 41.89 (-2.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered...

See More

Key Turning Points

3rd Resistance Point 46.27
2nd Resistance Point 45.60
1st Resistance Point 44.36
Last Price 41.89
1st Support Level 42.45
2nd Support Level 41.78
3rd Support Level 40.54

See More

52-Week High 44.92
Last Price 41.89
Fibonacci 61.8% 32.27
Fibonacci 50% 28.36
Fibonacci 38.2% 24.46
52-Week Low 11.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar